Deciphering vertebrate development, sorting out the roosters from the hens and taking on bird flu - dare we say, all in one fowl swoop - that is the job of CSIRO's Dr Mark Tizard, who has created a new microRNA catalogue for the humble chook.

Insect viral genes lead to discovery of human anti-apoptosis proteins.

Apollo Life Sciences signs agreement with Millipore for LIF protein.

In addition to its job as master regulator of apoptosis, p53 is also responsible for activating the tanning response in skin, a new study claims.

New evidence in rats suggests that marijuana may contain compounds that slow the memory loss associated with Alzheimer's disease.

Melbourne meditech Norwood Immunology (AIM:NIM) has recruited the first of 100 post-surgical melanoma patients into a phase II clinical trial of its thymus-rejuvenating technology, using the gonadotrophin releasing hormone (GNRH) analogue Lupron Depot.

Sydney proteomics R&D company Proteome Systems (ASX:PXL) has reported positive results from pre-clinical trials of its lead compound, the potent antioxidant EUK-189, in an animal model of Alzheimer's disease.

The Leach lecturer at the 2005 Lorne Protein conference has a persistent streak, Graeme O'Neill discovers.

Cancer therapeutics company Australian Cancer Technology (ASX:ACU) announced today its GPI-0100 vaccine adjuvant has produced an enhanced immune response in its Phase I clinical trial in men with relapsed prostate cancer.

Imugene (ASX: IMU) has been granted patent protection for its Receptor Mimic Technology (RMT) in the United States.

Imugene (ASX:IMU) has claimed a qualified success after a trial to test the ability of its receptor mimic technology (RMT) to prevent post-weaning diarrhoea in piglets.